ILD medications: asetylcysteine

PheWeb

ILD_ASETYLCYSTEINE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC R05CB01

1312

Check pre-conditions, main-only, mode, ICD version None

193

Check minimum number of events

Min. number of events 3

193

Include endpoints None

193

ILD_ASETYLCYSTEINE

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to ILD medications: asetylcysteine based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	185	83	102
Unadjusted prevalence (%)	0.06	0.05	0.08
Mean age at first event (years)	60.92	53.27	67.14

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: ILD_ASETYLCYSTEINE – ILD medications: asetylcysteine
GWS hits:

Survival analyses between endpoints

↥

Plot

before ILD medications: asetylcysteine
after ILD medications: asetylcysteine

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after ILD medications: asetylcysteine

↥